Chris Chambers

Pfizer (United Kingdom)

Papers

1

Total Citations

58

H-Index

1

About

Chris Chambers is a pioneering researcher in cellular signaling and high-throughput drug discovery, with a primary focus on intracellular calcium dynamics and G-protein coupled receptor (GPCR) pharmacology. His landmark 2003 paper, "Measuring Intracellular Calcium Fluxes in High Throughput Mode," has accumulated 58 citations and revolutionized the pharmaceutical industry's approach to drug screening. Chambers developed real-time calcium flux measurement techniques that enabled rapid pharmacological characterization of Gq-coupled receptors, transforming how researchers identify new surrogate ligands and screen compound libraries. This work bridged fundamental cell biology with industrial-scale drug discovery, establishing high-throughput calcium assays as an essential tool for GPCR-targeted therapeutics. Beyond this seminal contribution, Chambers has advanced methodologies for studying calcium signaling pathways, contributing to our understanding of receptor activation mechanisms and their therapeutic implications. His research continues to influence both academic laboratories and pharmaceutical R&D, where his techniques remain standard practice for characterizing GPCR activation and identifying novel drug candidates.

Research Focus

Key Achievements

1
H-Index
1
Papers
58
Total Citations
58
Avg Citations/Paper
🏆 Most Cited Paper
Measuring Intracellular Calcium Fluxes in High Throughput Mode
58 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Pfizer (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago